The effects of ethanol on angiogenesis after myocardial infarction, and preservation of angiogenesis with rosuvastatin after heavy drinking

Alcohol

Volumn 54, Issue , 2016, Pages 27-32

  Zhang, Yuying ^a   Yuan, Haitao ^a   Sun, Yongle ^a   Wang, Yong ^a   Wang, Aihong ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Angiogenesis; Endostatin; Ethanol; Myocardial infarction; Rosuvastatin; VEGF

Indexed keywords

ALCOHOL; CD34 ANTIGEN; ENDOSTATIN; ROSUVASTATIN; VASCULOTROPIN; CARDIOTONIC AGENT; VASCULOTROPIN A;

ACUTE HEART INFARCTION; ADULT; ALCOHOL CONSUMPTION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; RAT; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIAC MUSCLE; DOSE RESPONSE; DRUG EFFECTS; DRUG INTERACTION; HEART; HEART INFARCTION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENDOSTATINS; ETHANOL; HEART; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; ROSUVASTATIN CALCIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84976347325     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2016.05.003     Document Type: Article

References (33)

1. Antoniucci, D., Valenti, R., Moschi, G., Migliorini, A., Trapani, M., Santoro, G.M., et al. Relation between preintervention angiographic evidence of coronary collateral circulation and clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. The American Journal of Cardiology 89 (2002), 121–125.
2. Bonetti, P.O., Lerman, L.O., Napoli, C., Lerman, A., Statin effects beyond lipid lowering–Are they clinically relevant?. European Heart Journal 24 (2003), 225–248.
3. Brien, S.E., Ronksley, P.E., Turner, B.J., Mukamal, K.J., Ghali, W.A., Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: Systematic review and meta-analysis of interventional studies. BMJ (Clinical Research Ed.), 342, 2011, d636.
4. Brinton, E.A., Effects of ethanol intake on lipoproteins and atherosclerosis. Current Opinion in Lipidology 21 (2010), 346–351.
5. Carmeliet, P., Jain, R.K., Angiogenesis in cancer and other diseases. Nature 407 (2000), 249–257.
6. Collins, R., Armitage, J., Parish, S., Sleigh, P., Peto, R., Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial. Lancet 361 (2003), 2005–2016.
7. Corrao, G., Rubbiati, L., Bagnardi, V., Zambon, A., Poikolainen, K., Alcohol and coronary heart disease: A meta-analysis. Addiction 95 (2000), 1505–1523.
8. Crafts, T.D., Jensen, A.R., Blocher-Smith, E.C., Markel, T.A., Vascular endothelial growth factor: Therapeutic possibilities and challenges for the treatment of ischemia. Cytokine 71 (2015), 385–393.
9. Freedman, S.B., Isner, J.M., Therapeutic angiogenesis for ischemic cardiovascular disease. Journal of Molecular and Cellular Cardiology 33 (2001), 379–393.
10. Fujita, M., Sasayama, S., Reappraisal of functional importance of coronary collateral circulation. Cardiology 117 (2010), 246–252.
11. Gaziano, J.M., Buring, J.E., Breslow, J.L., Goldhaber, S.Z., Rosner, B., VanDenburgh, M., et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. The New England Journal of Medicine 329 (1993), 1829–1834.
12. Gu, J.W., Elam, J., Sartin, A., Li, W., Roach, R., Adair, T.H., Moderate levels of ethanol induce expression of vascular endothelial growth factor and stimulate angiogenesis. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 281 (2001), R365–R372.
13. Hong, S.J., Choi, S.C., Kim, J.S., Shim, W.J., Park, S.M., Ahn, C.M., et al. Low-dose versus moderate-dose atorvastatin after acute myocardial infarction: 8-month effects on coronary flow reserve and angiogenic cell mobilisation. Heart 96 (2010), 756–764.
14. Iribarren, C., Phelps, B.H., Darbinian, J.A., McCluskey, E.R., Quesenberry, C.P., Hytopoulos, E., et al. Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: A prospective nested case-control study. BMC Cardiovascular Disorders, 11, 2011, 31.
15. Koppes, L.L., Dekker, J.M., Hendriks, H.F., Bouter, L.M., Heine, R.J., Meta-analysis of the relationship between alcohol consumption and coronary heart disease and mortality in type 2 diabetic patients. Diabetologia 49 (2006), 648–652.
16. Li, Q., Olsen, B.R., Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice. The American Journal of Pathology 165 (2004), 415–424.
17. Liu, M., Wang, F., Wang, Y., Jin, R., Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: The role of inflammation. Cardiovascular Drugs and Therapy 23 (2009), 369–376.
18. Louboutin, J.P., Marusich, E., Gao, E., Agrawal, L., Koch, W.J., Strayer, D.S., Ethanol protects from injury due to ischemia and reperfusion by increasing vascularity via vascular endothelial growth factor. Alcohol 46 (2012), 441–454.
19. Makita, S., Onoda, T., Ohsawa, M., Tanaka, F., Segawa, T., Takahashi, T., et al. Influence of mild-to-moderate alcohol consumption on cardiovascular diseases in men from the general population. Atherosclerosis 224 (2012), 222–227.
20. Mannheim, D., Herrmann, J., Bonetti, P.O., Lavi, R., Lerman, L.O., Lerman, A., Simvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effect. Atherosclerosis 216 (2011), 283–291.
21. Miyamae, M., Rodriguez, M.M., Camacho, S.A., Diamond, I., Mochly-Rosen, D., Figueredo, V.M., Activation of epsilon protein kinase C correlates with a cardioprotective effect of regular ethanol consumption. Proceedings of the National Academy of Sciences of the United States of America 95 (1998), 8262–8267.
22. Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., et al. Heart disease and stroke statistics–2015 update: A report from the American Heart Association. Circulation 131 (2015), e29–e322.
23. Mukamal, K.J., Jensen, M.K., Grønbaek, M., Stampfer, M.J., Manson, J.E., Pischon, T., et al. Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation 112 (2005), 1406–1413.
24. Okada, M., Oba, Y., Yamawaki, H., Endostatin stimulates proliferation and migration of adult rat cardiac fibroblasts through PI3K/Akt pathway. European Journal of Pharmacology 750 (2015), 20–26.
25. Razvodovsky, Y.E., Alcohol-attributable fraction of ischemic heart disease mortality in Russia. ISRN Cardiology, 2013, 2013, 287869.
26. Ronksley, P.E., Brien, S.E., Turner, B.J., Mukamal, K.J., Ghali, W.A., Association of alcohol consumption with selected cardiovascular disease outcomes: A systematic review and meta-analysis. BMJ (Clinical Research Ed.), 342, 2011, d671.
27. Ruidavets, J.B., Ducimetière, P., Evans, A., Montaye, M., Haas, B., Bingham, A., et al. Patterns of alcohol consumption and ischaemic heart disease in culturally divergent countries: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). BMJ (Clinical Research Ed.), 341, 2010, c6077.
28. Samuel, S.M., Thirunavukkarasu, M., Penumathsa, S.V., Paul, D., Maulik, N., Akt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: Switching gears toward survival and longevity. Journal of Agricultural and Food Chemistry 56 (2008), 9692–9698.
29. Seko, Y., Fukuda, S., Nagai, R., Serum levels of endostatin, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy. Clinical Science (London, England: 1979) 106 (2004), 439–442.
30. Urbich, C., Dernbach, E., Zeiher, A.M., Dimmeler, S., Double-edged role of statins in angiogenesis signaling. Circulation Research 90 (2002), 737–744.
31. Weidner, N., Semple, J.P., Welch, W.R., Folkman, J., Tumor angiogenesis and metastasis–Correlation in invasive breast carcinoma. The New England Journal of Medicine 324 (1991), 1–8.
32. Zairis, M.N., Ambrose, J.A., Lyras, A.G., Thoma, M.A., Psarogianni, P.K., Psaltiras, P.G., et al. C Reactive protein, moderate alcohol consumption, and long term prognosis after successful coronary stenting: Four year results from the GENERATION study. Heart 90 (2004), 419–424.
33. Zaitone, S.A., Abo-Gresha, N.M., Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: Role of iNOS and VEGF. European Journal of Pharmacology 691 (2012), 134–142.